Astellas to acquire Audentes Therapeutics for $3bn
The acquisition is expected to be completed in the first quarter of 2020, subject to customary closing conditions,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Dec 19
The acquisition is expected to be completed in the first quarter of 2020, subject to customary closing conditions,…
25 Nov 19
The acquisition will enable Novartis to use the core commercial capabilities, including global cardiovascular field force of The…
25 Nov 19
The new manufacturing facility includes drug substance manufacturing, drug product manufacturing along with quality control labs
21 Nov 19
Lilly’s new investments are expected to create approximately 100 skilled manufacturing jobs at the Indianapolis facilities
20 Nov 19
Lumenis has created solutions for previously untreatable conditions, and designed advanced technologies to transform existing treatment methods
12 Nov 19
Kyowa develops, manufactures and sells branded and generic pharmaceutical products for patients in the Japanese market
07 Nov 19
The portfolio of products include OTC vitamins and food supplements, along with select products within the cardiovascular, diabetes,…
06 Nov 19
Takeda has developed the new tetravalent dengue vaccine candidate TAK-003 based on a live-attenuated dengue serotype 2 virus
16 Oct 19
Sanofi has developed Framingham facility after conducting several pilots for manufacturing biologics across its network
11 Oct 19
Founded in 2008, Ra Pharma is engaged in developing therapeutics for the treatment of diseases caused by uncontrolled…